Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.

Jennifer A. Quinn, David A. Reardon, Allan H. Friedman, Jeremy N. Rich, John H. Sampson, James M. Provenzale, Roger E. McLendon, Sridharan Gururangan, Darell D. Bigner, James E. Herndon, Nicholas Avgeropoulos, Jonathan Finlay, Sandra Tourt-Uhlig, Mary Lou Affronti, Brandon Evans, Valerie Stafford-Fox, Sara Zaknoen, Henry S. Friedman, Phase II Trial of Temozolomide in Patients With Progressive Low-Grade Glioma Journal of Clinical Oncology. ,vol. 21, pp. 646- 651 ,(2003) , 10.1200/JCO.2003.01.009

Magali Lecavalier-Barsoum, Harvey Quon, Bassam Abdulkarim, Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas Cochrane Database of Systematic Reviews. ,(2014) , 10.1002/14651858.CD007104.PUB2

A.A. Brandes, M. Ermani, U. Basso, P. Amistà, F. Berti, R. Scienza, A. Rotilio, G. Pinna, M. Gardiman, S. Monfardini, Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: A phase II study Annals of Oncology. ,vol. 12, pp. 255- 257 ,(2001) , 10.1023/A:1008336732273

M.J. van den Bent, M.J.B. Taphoorn, A.A. Brandes, J. Menten, R. Stupp, M. Frenay, O. Chinot, J.M. Kros, C.C.D. van der Rijt, Ch.J. Vecht, A. Allgeier, T. Gorlia, Phase II Study of First-Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors: The European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971 Journal of Clinical Oncology. ,vol. 21, pp. 2525- 2528 ,(2003) , 10.1200/JCO.2003.12.015

B. E. Johnson, T. Mazor, C. Hong, M. Barnes, K. Aihara, C. Y. McLean, S. D. Fouse, S. Yamamoto, H. Ueda, K. Tatsuno, S. Asthana, L. E. Jalbert, S. J. Nelson, A. W. Bollen, W. C. Gustafson, E. Charron, W. A. Weiss, I. V. Smirnov, J. S. Song, A. B. Olshen, S. Cha, Y. Zhao, R. A. Moore, A. J. Mungall, S. J. M. Jones, M. Hirst, M. A. Marra, N. Saito, H. Aburatani, A. Mukasa, M. S. Berger, S. M. Chang, B. S. Taylor, J. F. Costello, Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma Science. ,vol. 343, pp. 189- 193 ,(2014) , 10.1126/SCIENCE.1239947

Tracy Kerby, Hilary Calvert, Henry S. Friedman, Temozolomide and treatment of malignant glioma. Clinical Cancer Research. ,vol. 6, pp. 2585- 2597 ,(2000)

S Taillibert, K Hoang-Xuan, L Capelle, M Kujas, H Duffau, J Lejeune, M Polivka, E Criniere, Y Marie, K Mokhtari, A Carpentier, F Laigle, JM Simon, P Cornu, M Sanson, JY Delattre, None, Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p Deletions Journal of Clinical Oncology. ,vol. 22, pp. 3133- 3138 ,(2004) , 10.1200/JCO.2004.10.169

Martin J Van Den Bent, Alba A Brandes, Martin JB Taphoorn, Johan M Kros, Mathilde CM Kouwenhoven, Jean-Yves Delattre, Hans JJA Bernsen, Marc Frenay, Cees C Tijssen, Wolfgang Grisold, László Sipos, Roelien H Enting, Pim J French, Winand NM Dinjens, Charles J Vecht, Anouk Allgeier, Denis Lacombe, Thierry Gorlia, Khê Hoang-Xuan, None, Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951 Journal of Clinical Oncology. ,vol. 31, pp. 344- 350 ,(2013) , 10.1200/JCO.2012.43.2229

Rainer Goerne, Ulrich Bogdahn, Peter Hau, Procarbazine : A Traditional Drug in the Treatment of Malignant Gliomas Current Medicinal Chemistry. ,vol. 15, pp. 1376- 1387 ,(2008) , 10.2174/092986708784567707

Gregory Cairncross, Meihua Wang, Edward Shaw, Robert Jenkins, David Brachman, Jan Buckner, Karen Fink, Luis Souhami, Normand Laperriere, Walter Curran, Minesh Mehta, Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. Journal of Clinical Oncology. ,vol. 31, pp. 337- 343 ,(2013) , 10.1200/JCO.2012.43.2674